Radiolabeled EGFR TKI as predictive imaging biomarkers in NSCLC patients – an overview

Non-small cell lung cancer (NSCLC) has one of the highest cancer-related mortality rates worldwide. In a subgroup of NSCLC, tumor growth is driven by epidermal growth factor receptors (EGFR) that harbor an activating mutation. These patients are best treated with EGFR tyrosine kinase inhibitors (EGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Van De Stadt, Eveline, Yaqub, Maqsood, Jahangir, A. A., Hendrikse, Harry, Bahce, Idris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597357/
https://www.ncbi.nlm.nih.gov/pubmed/36313723
http://dx.doi.org/10.3389/fonc.2022.900450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597357/
https://www.ncbi.nlm.nih.gov/pubmed/36313723
http://dx.doi.org/10.3389/fonc.2022.900450

Ejemplares similares